Literature DB >> 20356708

[Low monocytic HLA-DR expression and risk of secondary infection].

A Chéron1, G Monneret, C Landelle, B Floccard, B Allaouchiche.   

Abstract

OBJECTIVES: The aim of this bibliographic review is to evaluate the usefulness of the measurement of HLA-DR expression on circulating monocytes (mHLA-DR) in predicting the development of nosocomial infections and unfavourable outcome in critically ill patients. DATA SOURCE: References obtained from the medical database PubMed in English and in French were reviewed. The keywords included separately or in combination were: HLA-DR antigens, sepsis, trauma, injuries, wounds, burns, stroke, pancreatitis, postoperative, prognostic, immunity, monocytic. DATA EXTRACTION: Data in selected articles were reviewed, clinical and basic science research relevant information were extracted. DATA SYNTHESIS: Low mHLA-DR expression appears as a marker for monocytic dysfunctions and immunosuppression, temporarily present in the majority of critically ill patients admitted to the ICU (sepsis, trauma injuries, postoperative, burns, pancreatitis and stroke). The decrease in mHLA-DR expression is a predictor of septic complications in all these clinical conditions. However, no predictive threshold value could be determined regarding unfavourable outcome.
CONCLUSION: The monitoring of mHLA-DR expression could be a biomarker to detect ICU patients at high risk of developing secondary nosocomial infections. Those patients could probably benefit of preemptive strategies to prevent these infections. Copyright 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20356708     DOI: 10.1016/j.annfar.2010.02.015

Source DB:  PubMed          Journal:  Ann Fr Anesth Reanim        ISSN: 0750-7658


  7 in total

1.  Glutamine in critically ill patients: is it a fundamental nutritional supplement?

Authors:  Paulo Martins
Journal:  Rev Bras Ter Intensiva       Date:  2016-06

2.  Reduced monocytic HLA-DR expression indicates immunosuppression in critically ill COVID-19 patients.

Authors:  Thibaud Spinetti; Cedric Hirzel; Michaela Fux; Laura N Walti; Patrick Schober; Frank Stueber; Markus M Luedi; Joerg C Schefold
Journal:  Anesth Analg       Date:  2020-06-04       Impact factor: 5.108

3.  Monocyte Tumor Necrosis Factor-α-Converting Enzyme Catalytic Activity and Substrate Shedding in Sepsis and Noninfectious Systemic Inflammation.

Authors:  David J P O'Callaghan; Kieran P O'Dea; Alasdair J Scott; Masao Takata; Anthony C Gordon
Journal:  Crit Care Med       Date:  2015-07       Impact factor: 7.598

Review 4.  Park 7: A Novel Therapeutic Target for Macrophages in Sepsis-Induced Immunosuppression.

Authors:  Yanwei Cheng; Tony N Marion; Xue Cao; Wanting Wang; Yu Cao
Journal:  Front Immunol       Date:  2018-11-13       Impact factor: 7.561

5.  Insights Into Mechanisms of Tumor and Immune System Interaction: Association With Wound Healing.

Authors:  Aleksandr V Ponomarev; Irina Zh Shubina
Journal:  Front Oncol       Date:  2019-10-25       Impact factor: 6.244

6.  Immune Dysfunction is Associated with Readmission in Survivors of Sepsis Following Infected Pancreatic Necrosis.

Authors:  Jiangtao Yin; Wenjian Mao; Xiaojia Xiao; Xianqiang Yu; Baiqiang Li; Faxi Chen; Jiajia Lin; Jing Zhou; Jing Zhou; Zhihui Tong; Lu Ke; Weiqin Li
Journal:  J Inflamm Res       Date:  2021-10-20

7.  Reduced Monocytic Human Leukocyte Antigen-DR Expression Indicates Immunosuppression in Critically Ill COVID-19 Patients.

Authors:  Thibaud Spinetti; Cedric Hirzel; Michaela Fux; Laura N Walti; Patrick Schober; Frank Stueber; Markus M Luedi; Joerg C Schefold
Journal:  Anesth Analg       Date:  2020-10       Impact factor: 6.627

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.